Back to search

Article

Specific targeting of MR1-antigen complexes using nanobodies

2026-03-25

Abstract excerpt

T cell receptor mimic (TCRm) antibodies and nanobodies that specifically bind peptide-HLA complexes have great therapeutic potential, as they can target polymorphic HLA on tumour cells furnishing peptides derived from tumour-associated antigens. MR1 is an MHC class-I-like molecule that exhibits limited polymorphism that binds and presents conserved metabolites, such as 5-OP-RU, derived from microbial riboflavin bi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1c561f12-ce08-536c-87d8-3ea4a3fd699c
DOI
10.64898/2026.03.22.713551
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Specific targeting of MR1-antigen complexes using nanobodiesDOI 10.64898/2026.03.22.713551
Select a neighboring publication to make it the new centre.